257 studies found for:    PROSTATIC HYPERPLASIA, BENIGN
Show Display Options
Rank Status Study
1 Completed Saw Palmetto Extract in Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Intervention: Drug: Saw Palmetto
2 Completed Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: Levitra (Vardenafil, BAY38-9456);   Drug: Placebo
3 Not yet recruiting Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia
Conditions: Prostatic Hyperplasia, Benign;   Prostatic Hypertrophy, Benign;   Genital Diseases, Male;   Lower Urinary Tract Symptoms;   Prostatic Diseases
Interventions: Procedure: Prostatic Arterial Embolization;   Procedure: Sham procedure
4 Recruiting Prostate Embolization for Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Interventions: Procedure: Prostatic Embolization;   Drug: Embosphere® Microspheres
5 Completed Pharmacovigilance Study To Evaluate Safety Of AVODART In Subjects With Benign Prostate Hyperplasia
Condition: Benign Prostatic Hyperplasia
Intervention:
6 Completed Effects of Chronic Use of Doxazosin in Men With Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Intervention: Drug: Doxazosin
7 Completed A Self-Administered Maneuver to Relieve Symptoms Suggestive of Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Intervention: Behavioral: the Digital Repetitive Infrapubic Pressure maneuver
8 Active, not recruiting A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization
Condition: Benign Prostatic Hyperplasia
Intervention: Device: GreenLight HPS
9 Completed
Has Results
A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: Silodosin;   Other: Placebo
10 Completed Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: Early combination therapy;   Drug: Delayed combination therapy
11 Completed
Has Results
Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)
Conditions: Benign Prostatic Hyperplasia;   Prostatic Hyperplasia
Interventions: Drug: Dutasteride 0.5mg capsule;   Drug: Dutasteride matched placebo
12 Recruiting Prostatic Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia (BPH)
Condition: Benign Prostatic Hyperplasia (BPH)
Intervention: Device: Prostate Artery Embolization
13 Completed
Has Results
A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia
Conditions: Erectile Dysfunction;   Benign Prostatic Hyperplasia
Interventions: Drug: Tadalafil;   Drug: Placebo
14 Completed
Has Results
The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months
Condition: Benign Prostatic Hyperplasia
Intervention: Drug: Silodosin
15 Completed Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Intervention: Drug: Silodosin
16 Recruiting Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)
Condition: Benign Prostatic Hyperplasia (BPH)
Intervention: Device: Vortx Rx - Histotripsy BPH Device
17 Recruiting Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia
Conditions: Nocturia;   Benign Prostatic Hyperplasia
Interventions: Drug: Silodosin;   Other: Laboratory tests;   Other: 3-days voiding diary;   Other: 12 weeks
18 Terminated MCS in Treating Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia
Interventions: Drug: MCS;   Drug: Placebo
19 Terminated Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia
Conditions: Benign Prostatic Hyperplasia;   Enlarged Prostate
Intervention: Drug: Lonidamine
20 Suspended Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (Canada)
Condition: Benign Prostatic Hyperplasia (BPH)
Intervention: Device: Vortx Rx - Histotripsy BPH Device

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years